Ping Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Sell
40,000
-5,000
-11% -$133K 0.21% 46
2026
Q2
$1.08M Buy
45,000
+20,000
+80% +$523K 0.27% 43
2026
Q1
$702K Hold
25,000
– – 0.2% 48
2025
Q4
$622K Buy
25,000
+10,000
+67% +$252K 0.18% 47
2025
Q3
$382K Hold
15,000
– – 0.13% 53
2025
Q2
$364K Hold
15,000
– – 0.09% 61
2025
Q1
$380K Hold
15,000
– – 0.14% 64
2024
Q4
$398K Buy
15,000
+1,000
+7% +$27.1K 0.1% 65
2024
Q3
$405K Buy
14,000
+3,000
+27% +$87.5K 0.11% 64
2024
Q2
$308K Buy
+11,000
New +$303K 0.09% 62

Other funds holding PFE

Ping Capital Management's PFE Position: Q3 2026 in Review

Ping Capital Management reduced its Pfizer (PFE) stake by 11% in Q3 2026, selling an estimated $133K and leaving 40,000 shares worth $1.14M. The position accounts for 0.21% of the portfolio, ranked #46.

Ping Capital Management first reported a position in PFE in Q2 2024 and has held it in 10 quarters since. 1,308 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Ping Capital Management held 40,000 shares of Pfizer worth $1.14M as of Q3 2026.
  • Ping Capital Management sold 5,000 Pfizer shares in Q3 2026, an estimated $133K.
  • Pfizer made up 0.21% of Ping Capital Management's portfolio in Q3 2026, its #46 holding.
  • Ping Capital Management first reported a position in Pfizer in Q2 2024 and has held it in 10 quarters since.
  • 1,308 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Ping Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.